Absence of constitutive EGF receptor activation in ovarian cancer cell lines.
about
EGFR/HER-targeted therapeutics in ovarian cancerProteinase requirements of epidermal growth factor-induced ovarian cancer cell invasionExpression and function of EGF-related peptides and their receptors in gynecological cancer--from basic science to therapy.Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs.The wound-healing effect of a glycoprotein fraction isolated from aloe vera.A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro.
P2860
Absence of constitutive EGF receptor activation in ovarian cancer cell lines.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Absence of constitutive EGF receptor activation in ovarian cancer cell lines.
@ast
Absence of constitutive EGF receptor activation in ovarian cancer cell lines.
@en
type
label
Absence of constitutive EGF receptor activation in ovarian cancer cell lines.
@ast
Absence of constitutive EGF receptor activation in ovarian cancer cell lines.
@en
prefLabel
Absence of constitutive EGF receptor activation in ovarian cancer cell lines.
@ast
Absence of constitutive EGF receptor activation in ovarian cancer cell lines.
@en
P2093
P2860
P356
P1476
Absence of constitutive EGF receptor activation in ovarian cancer cell lines
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.379
P407
P577
1996-08-01T00:00:00Z